<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="jah38674" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Am Heart Assoc</journal-id><journal-id journal-id-type="iso-abbrev">J Am Heart Assoc</journal-id><journal-id journal-id-type="pmc-domain-id">1888</journal-id><journal-id journal-id-type="pmc-domain">jaha</journal-id><journal-id journal-id-type="publisher-id">JAH3</journal-id><journal-title-group><journal-title>Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease</journal-title></journal-title-group><issn pub-type="epub">2047-9980</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10492975</article-id><article-id pub-id-type="pmcid-ver">PMC10492975.1</article-id><article-id pub-id-type="pmcaid">10492975</article-id><article-id pub-id-type="pmcaiid">10492975</article-id><article-id pub-id-type="pmid">37522176</article-id><article-id pub-id-type="doi">10.1161/JAHA.123.030431</article-id><article-id pub-id-type="publisher-id">JAH38674</article-id><article-id pub-id-type="other">JAHA/2023/030431-T</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Original Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Research</subject><subj-group subj-group-type="heading"><subject>Stroke</subject></subj-group></subj-group></article-categories><title-group><article-title>Cigarette Smoking as a Risk Factor for Hematoma Expansion in Primary Intracerebral Hemorrhage: Analysis From a Randomized Clinical Trial</article-title><alt-title alt-title-type="right-running-head">Smoking as a Risk for Hematoma Expansion in <styled-content style="fixed-case" toggle="no">ICH</styled-content></alt-title><alt-title alt-title-type="left-running-head">Schupper et al</alt-title></title-group><contrib-group><contrib id="jah38674-cr-0001" contrib-type="author" corresp="yes"><name name-style="western"><surname>Schupper</surname><given-names initials="AJ">Alexander J.</given-names></name><degrees>MD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3322-8138</contrib-id><xref rid="jah38674-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>alexander.schupper@mountsinai.org</email></address></contrib><contrib id="jah38674-cr-0002" contrib-type="author"><name name-style="western"><surname>Khorasanizadeh</surname><given-names initials="M">Mirhojjat</given-names></name><degrees>MD</degrees><xref rid="jah38674-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jah38674-cr-0003" contrib-type="author"><name name-style="western"><surname>Rossitto</surname><given-names initials="CP">Christina P.</given-names></name><degrees>BS</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8819-2198</contrib-id><xref rid="jah38674-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jah38674-cr-0004" contrib-type="author"><name name-style="western"><surname>Foster</surname><given-names initials="LD">Lydia D.</given-names></name><degrees>MS</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6856-5583</contrib-id><xref rid="jah38674-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="jah38674-cr-0005" contrib-type="author"><name name-style="western"><surname>Kellner</surname><given-names initials="CP">Christopher P.</given-names></name><degrees>MD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4604-8205</contrib-id><xref rid="jah38674-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jah38674-cr-0006" contrib-type="author"><name name-style="western"><surname>Suarez</surname><given-names initials="JI">Jose I.</given-names></name><degrees>MD</degrees><xref rid="jah38674-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="jah38674-cr-0007" contrib-type="author"><name name-style="western"><surname>Qureshi</surname><given-names initials="AI">Adnan I.</given-names></name><degrees>MD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4962-540X</contrib-id><xref rid="jah38674-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="jah38674-cr-0008" contrib-type="author"><name name-style="western"><surname>Majidi</surname><given-names initials="S">Shahram</given-names></name><degrees>MD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2971-6216</contrib-id><xref rid="jah38674-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jah38674-cr-0009" contrib-type="author"><collab collab-type="authors">ATACH&#8208;2 trial investigators<contrib-group><contrib id="jah38674-cr-0010" contrib-type="author"><name name-style="western"><surname>Qureshi</surname><given-names initials="AI">Adnan I.</given-names></name><xref rid="jah38674-cr-0009" ref-type="contrib"/></contrib><contrib id="jah38674-cr-0011" contrib-type="author"><name name-style="western"><surname>Palesch</surname><given-names initials="YY">Yuko Y.</given-names></name><xref rid="jah38674-cr-0009" ref-type="contrib"/></contrib><contrib id="jah38674-cr-0012" contrib-type="author"><name name-style="western"><surname>Martin</surname><given-names initials="RL">Renee L.</given-names></name><xref rid="jah38674-cr-0009" ref-type="contrib"/></contrib><contrib id="jah38674-cr-0013" contrib-type="author"><name name-style="western"><surname>Barsan</surname><given-names initials="WG">William G.</given-names></name><xref rid="jah38674-cr-0009" ref-type="contrib"/></contrib><contrib id="jah38674-cr-0014" contrib-type="author"><name name-style="western"><surname>Silbergleit</surname><given-names initials="R">Robert</given-names></name><xref rid="jah38674-cr-0009" ref-type="contrib"/></contrib><contrib id="jah38674-cr-0015" contrib-type="author"><name name-style="western"><surname>Hanley</surname><given-names initials="DF">Daniel F.</given-names></name><xref rid="jah38674-cr-0009" ref-type="contrib"/></contrib><contrib id="jah38674-cr-0016" contrib-type="author"><name name-style="western"><surname>Moy</surname><given-names initials="CS">Claudia S.</given-names></name><xref rid="jah38674-cr-0009" ref-type="contrib"/></contrib><contrib id="jah38674-cr-0017" contrib-type="author"><name name-style="western"><surname>Hsu</surname><given-names initials="CY">Chung Y.</given-names></name><xref rid="jah38674-cr-0009" ref-type="contrib"/></contrib><contrib id="jah38674-cr-0018" contrib-type="author"><name name-style="western"><surname>Steiner</surname><given-names initials="T">Thorsten</given-names></name><xref rid="jah38674-cr-0009" ref-type="contrib"/></contrib><contrib id="jah38674-cr-0019" contrib-type="author"><name name-style="western"><surname>Suarez</surname><given-names initials="JI">Jose I.</given-names></name><xref rid="jah38674-cr-0009" ref-type="contrib"/></contrib><contrib id="jah38674-cr-0020" contrib-type="author"><name name-style="western"><surname>Toyoda</surname><given-names initials="K">Kazunori</given-names></name><xref rid="jah38674-cr-0009" ref-type="contrib"/></contrib><contrib id="jah38674-cr-0021" contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="Y">Yongjun</given-names></name><xref rid="jah38674-cr-0009" ref-type="contrib"/></contrib><contrib id="jah38674-cr-0022" contrib-type="author"><name name-style="western"><surname>Yamamoto</surname><given-names initials="H">Haruko</given-names></name><xref rid="jah38674-cr-0009" ref-type="contrib"/></contrib><contrib id="jah38674-cr-0023" contrib-type="author"><name name-style="western"><surname>Yoon</surname><given-names initials="BW">Byung&#8208;Woo</given-names></name><xref rid="jah38674-cr-0009" ref-type="contrib"/></contrib></contrib-group>
</collab><xref rid="jah38674-note-0001" ref-type="author-notes">
<sup>*</sup>
</xref></contrib></contrib-group><aff id="jah38674-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Neurosurgery</named-content>
<institution>Mount Sinai Health System</institution>
<city>New York</city>
<named-content content-type="country-part">NY</named-content>
</aff><aff id="jah38674-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Public Health Sciences</named-content>
<institution>Medical University of South Carolina</institution>
<city>Charleston</city>
<named-content content-type="country-part">SC</named-content>
</aff><aff id="jah38674-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Neurology</named-content>
<institution>Johns Hopkins Hospital</institution>
<city>Baltimore</city>
<named-content content-type="country-part">MD</named-content>
</aff><aff id="jah38674-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Zeenat Qureshi Stroke Institute and Department of Neurology</named-content>
<institution>University of Missouri</institution>
<city>Columbia</city>
<named-content content-type="country-part">MO</named-content>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label>Correspondence to: Alexander J. Schupper, MD, Department of Neurosurgery, Mount Sinai Health System, 1468 Madison Ave, New York, NY 10029. Email: <email>alexander.schupper@mountsinai.org</email></corresp><fn id="jah38674-note-0001"><label>*</label><p>A complete list of the ATACH&#8208;2 trial investigators can be found in the Appendix at the end of the article.</p></fn></author-notes><pub-date pub-type="epub"><day>31</day><month>7</month><year>2023</year></pub-date><pub-date pub-type="collection"><day>01</day><month>8</month><year>2023</year></pub-date><volume>12</volume><issue seq="260">15</issue><issue-id pub-id-type="pmc-issue-id">445040</issue-id><issue-id pub-id-type="doi">10.1002/jah3.v12.15</issue-id><elocation-id>e030431</elocation-id><history><date date-type="received"><day>10</day><month>4</month><year>2023</year></date><date date-type="accepted"><day>26</day><month>6</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>08</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>11</day><month>09</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-09-11 06:25:21.203"><day>11</day><month>09</month><year>2023</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2023 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="JAH3-12-e030431.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:JAH3-12-e030431.pdf"/><abstract><sec id="jah38674-sec-0001"><title>Background</title><p>Cigarette smoking is a well&#8208;known risk factor for ischemic and hemorrhagic stroke. We evaluated the impact of smoking status on hematoma expansion and clinical outcome in patients with primary intracerebral hemorrhage.</p></sec><sec id="jah38674-sec-0002"><title>Methods and Results</title><p>This is a post hoc exploratory analysis of the ATACH (Antihypertensive Treatment at Acute Cerebral Hemorrhage)&#8208;2 trial. Patients with intracerebral hemorrhage were randomized into intensive blood pressure lowering (systolic blood pressure, &lt;139&#8201;mm&#8201;Hg) versus standard blood pressure lowering (systolic blood pressure, 140&#8211;179&#8201;mm&#8201;Hg) in this study. We compared the demographic characteristics; hematoma size, location, and expansion rate; and clinical outcome based on subjects' smoking status. Of a total of 914 patients in the trial with known smoking status, 439 (48%) patients were ever smokers (264 current smokers and 175 former smokers). Current and former smokers were younger and more likely to be men. Baseline Glasgow Coma Scale score and initial hematoma size did not vary based on smoking status. Ever smokers had higher rates of thalamic hemorrhage (42% versus 34%) and intraventricular hemorrhage (29% versus 23%); this rate was highest among former smokers versus current smokers (49% versus 35%, respectively). Ever smokers had a higher rate of hematoma expansion in 24&#8201;hours (adjusted relative risk [RR] [95% CI], 1.46 [1.08&#8211;1.96]) compared with nonsmokers on multivariate analysis. There was no significant difference in the rate of death and disability at 90&#8201;days between the 2 groups (adjusted RR [95% CI], 1.18 [0.998&#8211;1.40]).</p></sec><sec id="jah38674-sec-0003"><title>Conclusions</title><p>Our analysis demonstrates cigarette smoking as an independent predictor for hematoma expansion. There was no significant difference in death and disability based on smoking status.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="jah38674-kwd-0001">intracerebral hemorrhage</kwd><kwd id="jah38674-kwd-0002">outcomes</kwd><kwd id="jah38674-kwd-0003">randomized clinical trial</kwd><kwd id="jah38674-kwd-0004">smoking</kwd></kwd-group><kwd-group kwd-group-type="subject-categories"><title>Subject Categories</title><kwd>Cerebrovascular Disease/Stroke</kwd><kwd>Intracranial Hemorrhage</kwd><kwd>Vascular Disease</kwd></kwd-group><counts><fig-count count="0"/><table-count count="5"/><page-count count="9"/><word-count count="4741"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>01 August 2023</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.3.2 mode:remove_FC converted:11.08.2023</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="jah38674-ntgp-0001"><fn id="jah38674-note-0002"><p>For Sources of Funding and Disclosures, see page 8.</p></fn><fn id="jah38674-note-0003"><p>This article was sent to Neel S. Singhal, MD, PhD, Associate Editor, for review by expert referees, editorial decision, and final disposition.</p></fn></fn-group></notes></front><body id="jah38674-body-0001"><def-list list-content="abbreviations" id="jah38674-lp-0001"><title>Nonstandard Abbreviations and Acronyms</title><def-item><term id="jah38674-li-0001">ATACH</term><def id="jah38674-li-0002"><p>Antihypertensive Treatment of Acute Cerebral Hemorrhage</p></def></def-item><def-item><term id="jah38674-li-0003">ICH</term><def id="jah38674-li-0004"><p>intracerebral hemorrhage</p></def></def-item><def-item><term id="jah38674-li-0005">mRS</term><def id="jah38674-li-0006"><p>modified Rankin Scale</p></def></def-item><def-item><term id="jah38674-li-0007">SBP</term><def id="jah38674-li-0008"><p>systolic blood pressure</p></def></def-item></def-list><p>
<boxed-text position="anchor" content-type="box" id="jah38674-blkfxd-0001" orientation="portrait"><caption><title>Clinical Perspective</title></caption><sec id="jah38674-sec-0006"><title>What Is New?</title><p>
<list list-type="bullet" id="jah38674-list-0001"><list-item id="jah38674-li-0009"><p>From a novel post hoc analysis of the ATACH (Antihypertensive Treatment of Acute Cerebral Hemorrhage)&#8208;2 trial, cigarette smoking was found to be an independent predictor for hematoma expansion of intracerebral hemorrhage.</p></list-item></list>
</p></sec><sec id="jah38674-sec-0007"><title>What Are the Clinical Implications?</title><p>
<list list-type="bullet" id="jah38674-list-0002"><list-item id="jah38674-li-0010"><p>Although smokers had a greater rate of hematoma expansion at 24&#8201;hours, there were no differences between 90&#8208;day rates of death or disability.</p></list-item><list-item id="jah38674-li-0011"><p>This may aid providers and patients/families in understanding the impact of smoking in the setting of intracerebral hemorrhage.</p></list-item></list>
</p></sec></boxed-text>
</p><p>Intracerebral hemorrhage (ICH) accounts for 10% to 20% of all strokes and is associated with significant morbidity and mortality.<xref rid="jah38674-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref>, <xref rid="jah38674-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> In 2019, ICH caused 2.9&#8201;million deaths worldwide.<xref rid="jah38674-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> Several studies have shown cigarette smoking to be an independent risk factor for ICH.<xref rid="jah38674-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="jah38674-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="jah38674-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> This risk is especially prominent in young smokers.<xref rid="jah38674-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> Tobacco also exacerbates high blood pressure and has been linked to increased expression of biomarkers of cardiovascular disease, including levels of plasma fibrinogen and media&#8208;intima thickness.<xref rid="jah38674-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> Despite the detrimental consequences of tobacco on vascular health, the impact of cigarette smoking on clinical outcomes after ICH is not well understood. In fact, animal models have shown that cigarette smoking may have paradoxical neuroprotective effects via the cholinergic anti&#8208;inflammatory pathway mediated by nicotine.<xref rid="jah38674-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> A 2019 study found that nicotine receptor stimulation in mice reduced brain edema at 24 and 72&#8201;hours after surgery and improved neurologic outcomes.<xref rid="jah38674-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref>
</p><p>In human studies, data on the impact of cigarette smoking on ICH recovery have been conflicting. Some studies in patients with ICH have found no difference in clinical outcomes based on smoking history.<xref rid="jah38674-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="jah38674-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref> However, other studies have observed negative effects of tobacco use on ICH outcomes, including increased hematoma expansion and worse functional outcomes.<xref rid="jah38674-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="jah38674-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref>, <xref rid="jah38674-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> Therefore, a knowledge gap exists about the impact of cigarette smoking on the clinical outcomes of ICH. Using data from the ATACH (Antihypertensive Treatment of Acute Cerebral Hemorrhage)&#8208;2 trial,<xref rid="jah38674-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="jah38674-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> we assessed the impact of smoking status on hematoma expansion and clinical outcome after ICH.</p><sec sec-type="methods" id="jah38674-sec-0008"><title>METHODS</title><p>The data that support the findings of this study are available from the corresponding author on reasonable request. We conducted a post hoc exploratory analysis of ATACH&#8208;2 trial,<xref rid="jah38674-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> which was an international, randomized, open&#8208;label clinical trial to determine the efficacy of rapid lowering of systolic blood pressure in patients with acute spontaneous ICH. Institutional review board approval and participant consent were waived for the current study. A detailed protocol of the trial has been previously published. Briefly, patients with initial ICH volume &lt;60&#8201;mL, Glasgow Coma Scale (GCS) score of &gt;4, and systolic blood pressure (SBP) &#8805;180&#8201;mm&#8201;Hg were randomized in a 1:1 ratio to either intensive SBP lowering (target SBP, 110&#8211;139&#8201;mm&#8201;Hg) or standard SBP lowering (target SBP, 140&#8211;179&#8201;mm&#8201;Hg). Deidentified ATACH&#8208;2 trial data were analyzed via an internally derived data set from the original trial data archive. Patient demographic factors, including age, sex, race, ethnicity, and smoking status (current versus former versus never smoker), were collected. Current smokers were defined as subjects who were actively smoking during the time of enrollment, former smokers had previously regularly smoked but were not presently during enrollment, and never smokers had no history of smoking. Ever smokers were defined as either current or former smokers. Clinical parameters, such as initial GCS score and National Institutes of Health Stroke Scale score, were included. Radiographic factors, such as ICH volume and location, perihematomal edema volume, intraventricular hemorrhage, and presence of a spot sign, were recorded. Outcome measures, including modified Rankin Scale (mRS) score at 90&#8201;days, rates of hematoma expansion, and neurologic deterioration, and adverse events, including in&#8208;hospital mortality, were extracted. The following binary outcome variables were analyzed: 90&#8208;day mRS score of 0 to 3 versus 4 to 6, 90&#8208;day mRS score of 0 to 1 versus 2 to 6, hematoma expansion, neurologic deterioration, presence of any serious adverse event within 72&#8201;hours after randomization that was considered by the site investigator to be related to treatment, and death within 3&#8201;months after randomization. Hematoma expansion was defined as expansion of &#8805;33% in the volume of the hematoma on the computed tomography scan obtained at 24&#8201;hours after randomization, compared with the entry scan. Neurologic deterioration was defined as a decrease from baseline of &#8805;2 points in the GCS score or an increase of &#8805;4 points in the score on the National Institutes of Health Stroke Scale that was not related to sedation or hypnotic agent use and was sustained for at least 8&#8201;hours within the 24&#8201;hours after randomization.</p><sec id="jah38674-sec-0030"><title>Statistical Analysis</title><p>Patient parameters<xref rid="jah38674-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> were compared on the basis of subjects' smoking status. Baseline demographic variables were compared using &#967;<sup>2</sup> test, Fisher exact test, Wilcoxon test, or <italic toggle="yes">t</italic> test, as appropriate. Outcome measures were compared by using a generalized linear model with log&#8208;link function, Poisson distribution, and robust error estimate, adjusting for covariates included in the ATACH&#8208;2 trial primary analysis (age, randomized treatment, GCS category [3&#8211;11, 12&#8211;14, or 15], and presence of intraventricular hemorrhage) or associated with smoking status (sex and hemorrhage location [lobar/nonlobar]).</p></sec></sec><sec sec-type="results" id="jah38674-sec-0009"><title>RESULTS</title><sec id="jah38674-sec-0010"><title>Patient Demographics and Smoking Status</title><p>A total of 914 patients with known smoking status were enrolled in the trial. Male subjects were more likely to have ever smoked compared with female subjects (80.6% versus 19.4%; <italic toggle="yes">P</italic>&lt;0.001). As a cohort, 439 (48%) patients were ever smokers (264 current smokers and 175 former smokers). Current smokers were younger than former or ever smokers (Tables&#160;<xref rid="jah38674-tbl-0001" ref-type="table">1</xref> and <xref rid="jah38674-tbl-0002" ref-type="table">2</xref>).</p><table-wrap position="float" id="jah38674-tbl-0001" content-type="Table" orientation="portrait"><label>Table 1</label><caption><p>Baseline Characteristics by Smoking Status (Ever/Never)</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Characteristic</th><th align="left" rowspan="1" colspan="1">Ever smoker</th><th align="left" rowspan="1" colspan="1">Never smoker</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">P</italic> value<xref rid="jah38674-note-0005" ref-type="table-fn">*</xref>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age, mean (SD), y</td><td align="left" rowspan="1" colspan="1">61.1 (12.1)</td><td align="left" rowspan="1" colspan="1">62.9 (13.9)</td><td align="left" rowspan="1" colspan="1">0.0320</td></tr><tr><td align="left" colspan="4" rowspan="1">Sex, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Men</td><td align="left" rowspan="1" colspan="1">354 (80.6)</td><td align="left" rowspan="1" colspan="1">216 (45.5)</td><td align="left" rowspan="2" colspan="1">&lt;0.0001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Women</td><td align="left" rowspan="1" colspan="1">85 (19.4)</td><td align="left" rowspan="1" colspan="1">259 (54.5)</td></tr><tr><td align="left" colspan="4" rowspan="1">Race, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Asian</td><td align="left" rowspan="1" colspan="1">267 (60.8)</td><td align="left" rowspan="1" colspan="1">274 (57.7)</td><td align="left" rowspan="4" colspan="1">0.1193</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Black</td><td align="left" rowspan="1" colspan="1">56 (12.8)</td><td align="left" rowspan="1" colspan="1">55 (11.6)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">White</td><td align="left" rowspan="1" colspan="1">103 (23.5)</td><td align="left" rowspan="1" colspan="1">139 (29.3)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Other/unknown</td><td align="left" rowspan="1" colspan="1">13 (3)</td><td align="left" rowspan="1" colspan="1">7 (1.5)</td></tr><tr><td align="left" colspan="4" rowspan="1">Ethnicity, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Not Hispanic or Latino/unknown</td><td align="left" rowspan="1" colspan="1">410 (93.4)</td><td align="left" rowspan="1" colspan="1">437 (92)</td><td align="left" rowspan="2" colspan="1">0.4191</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Hispanic or Latino</td><td align="left" rowspan="1" colspan="1">29 (6.6)</td><td align="left" rowspan="1" colspan="1">38 (8)</td></tr><tr><td align="left" colspan="4" rowspan="1">Recruited at site in Asia, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">176 (40.1)</td><td align="left" rowspan="1" colspan="1">218 (45.9)</td><td align="left" rowspan="1" colspan="1">0.0767</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">263 (59.9)</td><td align="left" rowspan="1" colspan="1">257 (54.1)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="4" rowspan="1">Baseline GCS score, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">3&#8211;11</td><td align="left" rowspan="1" colspan="1">62 (14.1)</td><td align="left" rowspan="1" colspan="1">65 (13.7)</td><td align="left" rowspan="3" colspan="1">0.8866</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">12&#8211;14</td><td align="left" rowspan="1" colspan="1">123 (28)</td><td align="left" rowspan="1" colspan="1">140 (29.5)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">254 (57.9)</td><td align="left" rowspan="1" colspan="1">270 (56.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">NIHSS score, median (minimum&#8211;maximum)</td><td align="left" rowspan="1" colspan="1">11 (1&#8211;40)</td><td align="left" rowspan="1" colspan="1">10 (0&#8211;37)</td><td align="left" rowspan="1" colspan="1">0.8061</td></tr><tr><td align="left" colspan="4" rowspan="1">Baseline intracerebral hematoma volume&#8201;&gt;30 cm<sup>3</sup>, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">390 (89.4)</td><td align="left" rowspan="1" colspan="1">434 (92.7)</td><td align="left" rowspan="1" colspan="1">0.0822</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">46 (10.6)</td><td align="left" rowspan="1" colspan="1">34 (7.3)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Baseline edema volume in perihematoma region, median (minimum&#8211;maximum), mm<sup>3</sup>
</td><td align="left" rowspan="1" colspan="1">1.4 (0.3&#8211;28.3)</td><td align="left" rowspan="1" colspan="1">1.3 (0&#8211;27.3)</td><td align="left" rowspan="1" colspan="1">0.7006</td></tr><tr><td align="left" rowspan="1" colspan="1">Intracerebral hematoma volume, median (minimum maximum), mL</td><td align="left" rowspan="1" colspan="1">9.9 (0.9&#8211;85.2)</td><td align="left" rowspan="1" colspan="1">9.9 (0.2&#8211;79.1)</td><td align="left" rowspan="1" colspan="1">0.5167</td></tr><tr><td align="left" colspan="4" rowspan="1">Intraventricular hemorrhage, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">310 (71.1)</td><td align="left" rowspan="1" colspan="1">360 (76.9)</td><td align="left" rowspan="1" colspan="1">0.0458</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">126 (28.9)</td><td align="left" rowspan="1" colspan="1">108 (23.1)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="4" rowspan="1">Baseline location of hemorrhage, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Basal ganglia</td><td align="left" rowspan="1" colspan="1">205 (47)</td><td align="left" rowspan="1" colspan="1">258 (55.1)</td><td align="left" rowspan="4" colspan="1">0.0291</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Thalamus</td><td align="left" rowspan="1" colspan="1">184 (42.2)</td><td align="left" rowspan="1" colspan="1">158 (33.8)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Lobar</td><td align="left" rowspan="1" colspan="1">47 (10.8)</td><td align="left" rowspan="1" colspan="1">51 (10.9)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Pons/cerebellum</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="left" rowspan="1" colspan="1">1 (0.2)</td></tr><tr><td align="left" colspan="4" rowspan="1">Spot sign, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">35 (67.3)</td><td align="left" rowspan="1" colspan="1">31 (55.4)</td><td align="left" rowspan="2" colspan="1">0.2030</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">17 (32.7)</td><td align="left" rowspan="1" colspan="1">25 (44.6)</td></tr></tbody></table><table-wrap-foot id="jah38674-ntgp-0002"><fn id="jah38674-note-0017"><p>Race &#8220;Other&#8221; is any race that is not Asian, Black or White.</p></fn><fn id="jah38674-note-0004"><p>GCS indicates Glasgow Coma Scale; and NIHSS, National Institutes of Health Stroke Scale.</p></fn><fn id="jah38674-note-0005"><label>*</label><p>Determined using &#967;<sup>2</sup> test, Fisher exact test, Wilcoxon test, or <italic toggle="yes">t</italic> test, as appropriate.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="jah38674-tbl-0002" content-type="Table" orientation="portrait"><label>Table 2</label><caption><p>Baseline Characteristics by Smoking Status (Current/Former/Never)</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Characteristic</th><th align="left" rowspan="1" colspan="1">Current smoker</th><th align="left" rowspan="1" colspan="1">Former smoker</th><th align="left" rowspan="1" colspan="1">Never smoker</th><th align="left" rowspan="1" colspan="1">Current vs former vs never <italic toggle="yes">P</italic> value<xref rid="jah38674-note-0007" ref-type="table-fn">*</xref>
</th><th align="left" rowspan="1" colspan="1">Current vs former <italic toggle="yes">P</italic> value<xref rid="jah38674-note-0008" ref-type="table-fn">&#8224;</xref>
</th><th align="left" rowspan="1" colspan="1">Former vs never <italic toggle="yes">P</italic> value<xref rid="jah38674-note-0007" ref-type="table-fn">*</xref>
</th><th align="left" rowspan="1" colspan="1">Current vs never <italic toggle="yes">P</italic> value<xref rid="jah38674-note-0008" ref-type="table-fn">&#8224;</xref>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age, mean (SD), y</td><td align="left" rowspan="1" colspan="1">58.1 (11.3)</td><td align="left" rowspan="1" colspan="1">65.5 (11.9)</td><td align="left" rowspan="1" colspan="1">62.9 (13.9)</td><td align="left" rowspan="1" colspan="1">&lt;0.0001</td><td align="left" rowspan="1" colspan="1">&lt;0.0001</td><td align="left" rowspan="1" colspan="1">0.0200</td><td align="left" rowspan="1" colspan="1">&lt;0.0001</td></tr><tr><td align="left" colspan="8" rowspan="1">Sex, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Men</td><td align="left" rowspan="1" colspan="1">214 (81.1)</td><td align="left" rowspan="1" colspan="1">140 (80)</td><td align="left" rowspan="1" colspan="1">216 (45.5)</td><td align="left" rowspan="2" colspan="1">&lt;0.0001</td><td align="left" rowspan="2" colspan="1">0.7830</td><td align="left" rowspan="2" colspan="1">&lt;0.0001</td><td align="left" rowspan="2" colspan="1">&lt;0.0001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Women</td><td align="left" rowspan="1" colspan="1">50 (18.9)</td><td align="left" rowspan="1" colspan="1">35 (20)</td><td align="left" rowspan="1" colspan="1">259 (54.5)</td></tr><tr><td align="left" colspan="8" rowspan="1">Race, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Asian</td><td align="left" rowspan="1" colspan="1">179 (67.8)</td><td align="left" rowspan="1" colspan="1">88 (50.3)</td><td align="left" rowspan="1" colspan="1">274 (57.7)</td><td align="left" rowspan="4" colspan="1">0.0002</td><td align="left" rowspan="4" colspan="1">&lt;0.0001</td><td align="left" rowspan="4" colspan="1">0.3673</td><td align="left" rowspan="4" colspan="1">0.0004</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Black</td><td align="left" rowspan="1" colspan="1">34 (12.9)</td><td align="left" rowspan="1" colspan="1">22 (12.6)</td><td align="left" rowspan="1" colspan="1">55 (11.6)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">White</td><td align="left" rowspan="1" colspan="1">42 (15.9)</td><td align="left" rowspan="1" colspan="1">61 (34.9)</td><td align="left" rowspan="1" colspan="1">139 (29.3)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Other/unknown</td><td align="left" rowspan="1" colspan="1">9 (3.4)</td><td align="left" rowspan="1" colspan="1">4 (2.3)</td><td align="left" rowspan="1" colspan="1">7 (1.5)</td></tr><tr><td align="left" colspan="8" rowspan="1">Ethnicity, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Not Hispanic or Latino/unknown</td><td align="left" rowspan="1" colspan="1">248 (93.9)</td><td align="left" rowspan="1" colspan="1">162 (92.6)</td><td align="left" rowspan="1" colspan="1">437 (92)</td><td align="left" rowspan="2" colspan="1">0.6242</td><td align="left" rowspan="2" colspan="1"/><td align="left" rowspan="2" colspan="1"/><td align="left" rowspan="2" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Hispanic or Latino</td><td align="left" rowspan="1" colspan="1">16 (6.1)</td><td align="left" rowspan="1" colspan="1">13 (7.4)</td><td align="left" rowspan="1" colspan="1">38 (8)</td></tr><tr><td align="left" colspan="8" rowspan="1">Recruited at site in Asia, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">89 (33.7)</td><td align="left" rowspan="1" colspan="1">87 (49.7)</td><td align="left" rowspan="1" colspan="1">218 (45.9)</td><td align="left" rowspan="2" colspan="1">0.0009</td><td align="left" rowspan="2" colspan="1">0.0008</td><td align="left" rowspan="2" colspan="1">0.3868</td><td align="left" rowspan="2" colspan="1">0.0013</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">175 (66.3)</td><td align="left" rowspan="1" colspan="1">88 (50.3)</td><td align="left" rowspan="1" colspan="1">257 (54.1)</td></tr><tr><td align="left" colspan="8" rowspan="1">Baseline GCS score, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">3&#8211;11</td><td align="left" rowspan="1" colspan="1">34 (12.9)</td><td align="left" rowspan="1" colspan="1">28 (16)</td><td align="left" rowspan="1" colspan="1">65 (13.7)</td><td align="left" rowspan="3" colspan="1">0.8223</td><td align="left" rowspan="3" colspan="1"/><td align="left" rowspan="3" colspan="1"/><td align="left" rowspan="3" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">12&#8211;14</td><td align="left" rowspan="1" colspan="1">78 (29.5)</td><td align="left" rowspan="1" colspan="1">45 (25.7)</td><td align="left" rowspan="1" colspan="1">140 (29.5)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">152 (57.6)</td><td align="left" rowspan="1" colspan="1">102 (58.3)</td><td align="left" rowspan="1" colspan="1">270 (56.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">NIHSS score, median (minimum&#8211;maximum)</td><td align="left" rowspan="1" colspan="1">11 (1&#8211;40)</td><td align="left" rowspan="1" colspan="1">11 (1&#8211;40)</td><td align="left" rowspan="1" colspan="1">10 (0&#8211;37)</td><td align="left" rowspan="1" colspan="1">0.9665</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="8" rowspan="1">Baseline intracerebral hematoma volume &gt;30&#8201;mL, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">232 (88.9)</td><td align="left" rowspan="1" colspan="1">158 (90.3)</td><td align="left" rowspan="1" colspan="1">434 (92.7)</td><td align="left" rowspan="1" colspan="1">0.1946</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">29 (11.1)</td><td align="left" rowspan="1" colspan="1">17 (9.7)</td><td align="left" rowspan="1" colspan="1">34 (7.3)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Baseline edema volume in perihematoma region, median (minimum&#8211;maximum), mL</td><td align="left" rowspan="1" colspan="1">1.40 (0.34&#8211;28.30)</td><td align="left" rowspan="1" colspan="1">1.43 (0.73&#8211;19.82)</td><td align="left" rowspan="1" colspan="1">1.35 (0&#8211;27.39)</td><td align="left" rowspan="1" colspan="1">0.9191</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Intracerebral hematoma volume, median (minimum&#8211;maximum), mL</td><td align="left" rowspan="1" colspan="1">10.01 (0.98&#8211;65.50)</td><td align="left" rowspan="1" colspan="1">9.81 (0.23&#8211;85.21)</td><td align="left" rowspan="1" colspan="1">9.91 (0.28&#8211;79.16)</td><td align="left" rowspan="1" colspan="1">0.8086</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="8" rowspan="1">Intraventricular hemorrhage, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">196 (75.1)</td><td align="left" rowspan="1" colspan="1">114 (65.1)</td><td align="left" rowspan="1" colspan="1">360 (76.9)</td><td align="left" rowspan="2" colspan="1">0.0091</td><td align="left" rowspan="2" colspan="1">0.0246</td><td align="left" rowspan="2" colspan="1">0.0025</td><td align="left" rowspan="2" colspan="1">0.5782</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">65 (24.9)</td><td align="left" rowspan="1" colspan="1">61 (34.9)</td><td align="left" rowspan="1" colspan="1">108 (23.1)</td></tr><tr><td align="left" colspan="8" rowspan="1">Baseline location of hemorrhage, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Basal ganglia</td><td align="left" rowspan="1" colspan="1">137 (52.5)</td><td align="left" rowspan="1" colspan="1">68 (38.9)</td><td align="left" rowspan="1" colspan="1">258 (55.1)</td><td align="left" rowspan="4" colspan="1">0.0064</td><td align="left" rowspan="4" colspan="1">0.0201</td><td align="left" rowspan="4" colspan="1">0.0009</td><td align="left" rowspan="4" colspan="1">0.7473</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Thalamus</td><td align="left" rowspan="1" colspan="1">98 (37.5)</td><td align="left" rowspan="1" colspan="1">86 (49.1)</td><td align="left" rowspan="1" colspan="1">158 (33.8)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Lobar</td><td align="left" rowspan="1" colspan="1">26 (10)</td><td align="left" rowspan="1" colspan="1">21 (12)</td><td align="left" rowspan="1" colspan="1">51 (10.9)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Pons/cerebellum</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="left" rowspan="1" colspan="1">1 (0.2)</td></tr><tr><td align="left" colspan="8" rowspan="1">Spot sign, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">21 (70)</td><td align="left" rowspan="1" colspan="1">14 (63.6)</td><td align="left" rowspan="1" colspan="1">31 (55.4)</td><td align="left" rowspan="2" colspan="1">0.3992</td><td align="left" rowspan="2" colspan="1"/><td align="left" rowspan="2" colspan="1"/><td align="left" rowspan="2" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">9 (30)</td><td align="left" rowspan="1" colspan="1">8 (36.4)</td><td align="left" rowspan="1" colspan="1">25 (44.6)</td></tr></tbody></table><table-wrap-foot id="jah38674-ntgp-0003"><fn id="jah38674-note-0006"><p>GCS indicates Glasgow Coma Scale; and NIHSS, National Institutes of Health Stroke Scale.</p></fn><fn id="jah38674-note-0018"><p>Race &#8220;Other&#8221; is any race that is not Asian, Black or White.</p></fn><fn id="jah38674-note-0007"><label>*</label><p>Determined using &#967;<sup>2</sup> test, Fisher exact test, Kruskal&#8208;Wallis test, or ANOVA, as appropriate.</p></fn><fn id="jah38674-note-0008"><label>
<sup>&#8224;</sup>
</label><p>Determined using &#967;<sup>2</sup> test, Fisher exact test, Wilcoxon test, or <italic toggle="yes">t</italic> test, as appropriate.</p></fn></table-wrap-foot></table-wrap></sec><sec id="jah38674-sec-0011"><title>ICH Characteristics and Subject Presentation</title><p>There was no difference in the baseline GCS score or National Institutes of Health Stroke Scale score based on smoking status. Initial hematoma size was also not different based on smoking status (9.9&#8201;versus 9.9&#8201;mL; <italic toggle="yes">P</italic>=0.5167). Ever smokers had a higher rate of thalamic hemorrhage (42.2% versus 33.8%), but no difference in rates of lobar hemorrhage (10.8% versus 10.9%). Ever smokers had higher rates of intraventricular hemorrhage (29% versus 23%; <italic toggle="yes">P</italic>=0.0458) (Table&#160;<xref rid="jah38674-tbl-0001" ref-type="table">1</xref>). Ever smokers also had a higher rate of hematoma expansion in 24 hours (adjusted relative risk [RR] [95% CI], 1.46 [1.08&#8211;1.96]) (Tables&#160;<xref rid="jah38674-tbl-0003" ref-type="table">3</xref> and <xref rid="jah38674-tbl-0004" ref-type="table">4</xref>) compared with nonsmokers after adjusting for confounding factors (Table&#160;<xref rid="jah38674-tbl-0005" ref-type="table">5</xref>).</p><table-wrap position="float" id="jah38674-tbl-0003" content-type="Table" orientation="portrait"><label>Table 3</label><caption><p>Outcomes by Smoking Status (Ever/Never)</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Outcome</th><th align="left" rowspan="1" colspan="1">Ever smoker</th><th align="left" rowspan="1" colspan="1">Never smoker</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">P</italic> value<xref rid="jah38674-note-0010" ref-type="table-fn">*</xref>
</th></tr></thead><tbody><tr><td align="left" colspan="4" rowspan="1">90&#8208;d mRS score 4&#8211;6, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">258 (61.1)</td><td align="left" rowspan="1" colspan="1">295 (64.6)</td><td align="left" rowspan="2" colspan="1">0.2952</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">164 (38.9)</td><td align="left" rowspan="1" colspan="1">162 (35.4)</td></tr><tr><td align="left" colspan="4" rowspan="1">90&#8208;d mRS score 1&#8211;2, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">311 (73.7)</td><td align="left" rowspan="1" colspan="1">333 (72.9)</td><td align="left" rowspan="2" colspan="1">0.7811</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">111 (26.3)</td><td align="left" rowspan="1" colspan="1">124 (27.1)</td></tr><tr><td align="left" colspan="4" rowspan="1">Hematoma expansion, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">288 (74.4)</td><td align="left" rowspan="1" colspan="1">345 (82.3)</td><td align="left" rowspan="2" colspan="1">0.0062</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">99 (25.6)</td><td align="left" rowspan="1" colspan="1">74 (17.7)</td></tr><tr><td align="left" colspan="4" rowspan="1">Neurologic deterioration within 24&#8201;h, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">402 (91.6)</td><td align="left" rowspan="1" colspan="1">437 (92)</td><td align="left" rowspan="2" colspan="1">0.8137</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">37 (8.4)</td><td align="left" rowspan="1" colspan="1">38 (8)</td></tr><tr><td align="left" colspan="4" rowspan="1">Treatment&#8208;related serious adverse event within 72&#8201;h, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">433 (98.6)</td><td align="left" rowspan="1" colspan="1">470 (98.9)</td><td align="left" rowspan="2" colspan="1">0.6635</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">6 (1.4)</td><td align="left" rowspan="1" colspan="1">5 (1.1)</td></tr><tr><td align="left" colspan="4" rowspan="1">Any serious adverse event within 3&#8201;mo, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">342 (77.9)</td><td align="left" rowspan="1" colspan="1">382 (80.4)</td><td align="left" rowspan="2" colspan="1">0.3489</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">97 (22.1)</td><td align="left" rowspan="1" colspan="1">93 (19.6)</td></tr><tr><td align="left" colspan="4" rowspan="1">Hypotension within 72&#8201;h, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">435 (99.1)</td><td align="left" rowspan="1" colspan="1">471 (99.2)</td><td align="left" rowspan="2" colspan="1">0.9108</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">4 (0.9)</td><td align="left" rowspan="1" colspan="1">4 (0.8)</td></tr><tr><td align="left" colspan="4" rowspan="1">Death, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">411 (93.6)</td><td align="left" rowspan="1" colspan="1">450 (94.7)</td><td align="left" rowspan="2" colspan="1">0.4712</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">28 (6.4)</td><td align="left" rowspan="1" colspan="1">25 (5.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">24&#8208;h Edema volume in perihematoma region, median (minimum&#8211;maximum), mm<sup>3</sup>
</td><td align="left" rowspan="1" colspan="1">2117.6 (7.4&#8211;37 537.7)</td><td align="left" rowspan="1" colspan="1">1891.2 (30.1&#8211;31 533.9)</td><td align="left" rowspan="1" colspan="1">0.1179</td></tr></tbody></table><table-wrap-foot id="jah38674-ntgp-0004"><fn id="jah38674-note-0009"><p>mRS indicates modified Rankin Scale.</p></fn><fn id="jah38674-note-0010"><label>*</label><p>Determined using &#967;<sup>2</sup> test, Fisher exact test, Wilcoxon test, or <italic toggle="yes">t</italic> test, as appropriate.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="jah38674-tbl-0004" content-type="Table" orientation="portrait"><label>Table 4</label><caption><p>Outcomes by Smoking Status (Current/Former/Never)</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Characteristic</th><th align="left" rowspan="1" colspan="1">Current smoker</th><th align="left" rowspan="1" colspan="1">Former smoker</th><th align="left" rowspan="1" colspan="1">Never smoker</th><th align="left" rowspan="1" colspan="1">Current vs former vs never <italic toggle="yes">P</italic> value<xref rid="jah38674-note-0012" ref-type="table-fn">*</xref>
</th><th align="left" rowspan="1" colspan="1">Current vs former <italic toggle="yes">P</italic> value<xref rid="jah38674-note-0013" ref-type="table-fn">&#8224;</xref>
</th><th align="left" rowspan="1" colspan="1">Former vs never <italic toggle="yes">P</italic> value<xref rid="jah38674-note-0013" ref-type="table-fn">&#8224;</xref>
</th><th align="left" rowspan="1" colspan="1">Current vs never <italic toggle="yes">P</italic> value<xref rid="jah38674-note-0013" ref-type="table-fn">&#8224;</xref>
</th></tr></thead><tbody><tr><td align="left" colspan="8" rowspan="1">90&#8208;d mRS score 4&#8211;6, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">167 (66.5)</td><td align="left" rowspan="1" colspan="1">91 (53.2)</td><td align="left" rowspan="1" colspan="1">295 (64.6)</td><td align="left" rowspan="2" colspan="1">0.0121</td><td align="left" rowspan="2" colspan="1">0.0059</td><td align="left" rowspan="2" colspan="1">0.0094</td><td align="left" rowspan="2" colspan="1">0.5962</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">84 (33.5)</td><td align="left" rowspan="1" colspan="1">80 (46.8)</td><td align="left" rowspan="1" colspan="1">162 (35.4)</td></tr><tr><td align="left" colspan="8" rowspan="1">90&#8208;d mRS score 1&#8211;2, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">179 (71.31)</td><td align="left" rowspan="1" colspan="1">132 (77.19)</td><td align="left" rowspan="1" colspan="1">333 (72.87)</td><td align="left" rowspan="2" colspan="1">0.3923</td><td align="left" rowspan="2" colspan="1"/><td align="left" rowspan="2" colspan="1"/><td align="left" rowspan="2" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">72 (28.69)</td><td align="left" rowspan="1" colspan="1">39 (22.81)</td><td align="left" rowspan="1" colspan="1">124 (27.13)</td></tr><tr><td align="left" colspan="8" rowspan="1">Hematoma expansion, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">176 (77.5)</td><td align="left" rowspan="1" colspan="1">112 (70)</td><td align="left" rowspan="1" colspan="1">345 (82.3)</td><td align="left" rowspan="2" colspan="1">0.0049</td><td align="left" rowspan="2" colspan="1">0.0944</td><td align="left" rowspan="2" colspan="1">0.0011</td><td align="left" rowspan="2" colspan="1">0.1399</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">51 (22.5)</td><td align="left" rowspan="1" colspan="1">48 (30)</td><td align="left" rowspan="1" colspan="1">74 (17.7)</td></tr><tr><td align="left" colspan="8" rowspan="1">Neurologic deterioration within 24&#8201;h, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">241 (91.3)</td><td align="left" rowspan="1" colspan="1">161 (92)</td><td align="left" rowspan="1" colspan="1">437 (92)</td><td align="left" rowspan="2" colspan="1">0.9388</td><td align="left" rowspan="2" colspan="1"/><td align="left" rowspan="2" colspan="1"/><td align="left" rowspan="2" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">23 (8.7)</td><td align="left" rowspan="1" colspan="1">14 (8)</td><td align="left" rowspan="1" colspan="1">38 (8)</td></tr><tr><td align="left" colspan="8" rowspan="1">Treatment&#8208;related serious adverse event within 72&#8201;h, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">260 (98.5)</td><td align="left" rowspan="1" colspan="1">173 (98.9)</td><td align="left" rowspan="1" colspan="1">470 (98.9)</td><td align="left" rowspan="2" colspan="1">0.9187</td><td align="left" rowspan="2" colspan="1"/><td align="left" rowspan="2" colspan="1"/><td align="left" rowspan="2" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">4 (1.5)</td><td align="left" rowspan="1" colspan="1">2 (1.1)</td><td align="left" rowspan="1" colspan="1">5 (1.1)</td></tr><tr><td align="left" colspan="8" rowspan="1">Any serious adverse event within 3&#8201;mo, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">218 (82.6)</td><td align="left" rowspan="1" colspan="1">124 (70.9)</td><td align="left" rowspan="1" colspan="1">382 (80.4)</td><td align="left" rowspan="2" colspan="1">0.0080</td><td align="left" rowspan="2" colspan="1">0.0038</td><td align="left" rowspan="2" colspan="1">0.0092</td><td align="left" rowspan="2" colspan="1">0.4726</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">46 (17.4)</td><td align="left" rowspan="1" colspan="1">51 (29.1)</td><td align="left" rowspan="1" colspan="1">93 (19.6)</td></tr><tr><td align="left" colspan="8" rowspan="1">Hypotension within 72&#8201;h, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">261 (98.9)</td><td align="left" rowspan="1" colspan="1">174 (99.4)</td><td align="left" rowspan="1" colspan="1">471 (99.2)</td><td align="left" rowspan="2" colspan="1">0.8977</td><td align="left" rowspan="2" colspan="1"/><td align="left" rowspan="2" colspan="1"/><td align="left" rowspan="2" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">3 (1.1)</td><td align="left" rowspan="1" colspan="1">1 (0.6)</td><td align="left" rowspan="1" colspan="1">4 (0.8)</td></tr><tr><td align="left" colspan="8" rowspan="1">Death, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">256 (97)</td><td align="left" rowspan="1" colspan="1">155 (88.6)</td><td align="left" rowspan="1" colspan="1">450 (94.7)</td><td align="left" rowspan="2" colspan="1">0.0009</td><td align="left" rowspan="2" colspan="1">0.0004</td><td align="left" rowspan="2" colspan="1">0.0060</td><td align="left" rowspan="2" colspan="1">0.1591</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">8 (3)</td><td align="left" rowspan="1" colspan="1">20 (11.4)</td><td align="left" rowspan="1" colspan="1">25 (5.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">24&#8208;h Edema volume in perihematoma region, median (minimum&#8211;maximum), mm<sup>3</sup>
</td><td align="left" rowspan="1" colspan="1">2060.2 (28.7&#8211;27 595.8)</td><td align="left" rowspan="1" colspan="1">2347.8 (7.4&#8211;37 537.7)</td><td align="left" rowspan="1" colspan="1">1891.2 (30.1&#8211;31 533.9)</td><td align="left" rowspan="1" colspan="1">0.2789</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot id="jah38674-ntgp-0005"><fn id="jah38674-note-0011"><p>mRS indicates modified Rankin Scale.</p></fn><fn id="jah38674-note-0012"><label>*</label><p>Determined using &#967;<sup>2</sup> test, Fisher exact test, Kruskal&#8208;Wallis test, or ANOVA, as appropriate.</p></fn><fn id="jah38674-note-0013"><label>
<sup>&#8224;</sup>
</label><p>Determined using &#967;<sup>2</sup> test, Fisher exact test, Wilcoxon test, or <italic toggle="yes">t</italic> test, as appropriate.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="jah38674-tbl-0005" content-type="Table" orientation="portrait"><label>Table 5</label><caption><p>Model Results</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" style="border-bottom:solid 1px #000000" colspan="1">Variable</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" rowspan="1">Ever vs never smoker RR<xref rid="jah38674-note-0015" ref-type="table-fn">*</xref>
</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Unadjusted RR (95% CI)</th><th align="left" rowspan="1" colspan="1">Adjusted RR (95% CI)<xref rid="jah38674-note-0016" ref-type="table-fn">&#8224;</xref>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">90&#8208;d mRS score 4&#8211;6</td><td align="left" rowspan="1" colspan="1">1.0963 (0.9230&#8211;1.3022)</td><td align="left" rowspan="1" colspan="1">1.1797 (0.9975&#8211;1.3951)</td></tr><tr><td align="left" rowspan="1" colspan="1">90&#8208;d mRS score 1&#8211;2</td><td align="left" rowspan="1" colspan="1">0.9694 (0.7785&#8211;1.2071)</td><td align="left" rowspan="1" colspan="1">0.8926 (0.7155&#8211;1.1135)</td></tr><tr><td align="left" rowspan="1" colspan="1">Hematoma expansion</td><td align="left" rowspan="1" colspan="1">1.4485 (1.1084&#8211;1.8929)</td><td align="left" rowspan="1" colspan="1">1.4574 (1.0846&#8211;1.9583)</td></tr><tr><td align="left" rowspan="1" colspan="1">Neurologic deterioration within 24&#8201;h</td><td align="left" rowspan="1" colspan="1">1.0535 (0.6828&#8211;1.6255)</td><td align="left" rowspan="1" colspan="1">1.2298 (0.7728&#8211;1.9572)</td></tr><tr><td align="left" rowspan="1" colspan="1">Any serious adverse event within 3&#8201;mo</td><td align="left" rowspan="1" colspan="1">1.1285 (0.8762&#8211;1.4536)</td><td align="left" rowspan="1" colspan="1">1.1900 (0.9078&#8211;1.5601)</td></tr><tr><td align="left" rowspan="1" colspan="1">Death</td><td align="left" rowspan="1" colspan="1">1.2118 (0.7180&#8211;2.0454)</td><td align="left" rowspan="1" colspan="1">1.2442 (0.6827&#8211;2.2675)</td></tr></tbody></table><table-wrap-foot id="jah38674-ntgp-0006"><fn id="jah38674-note-0014"><p>mRS indicates modified Rankin Scale; and RR, relative risk.</p></fn><fn id="jah38674-note-0015"><label>*</label><p>Results from Poisson regression model, consistent with primary analysis.</p></fn><fn id="jah38674-note-0016"><label>
<sup>&#8224;</sup>
</label><p>Covariates include age, randomized treatment, Glasgow Coma Scale category (3&#8211;11, 12&#8211;14, or 15), presence of intraventricular hemorrhage, sex, and hemorrhage location (lobar/nonlobar). Covariates included were those in the primary analysis or significantly associated (<italic toggle="yes">P</italic>&lt;0.05) with smoking status.</p></fn></table-wrap-foot></table-wrap></sec><sec id="jah38674-sec-0012"><title>Patient Outcomes and Smoking Status</title><p>There were no differences between rates of good outcome measures (mRS score 1&#8211;2; adjusted RR [95% CI], 0.89 [0.72&#8211;1.11]) between ever and never smokers. Despite ever smokers having higher rates of hematoma expansion (adjusted RR [95% CI], 1.46 [1.08&#8211;1.96]), rates of neurologic deterioration within 24&#8201;hours did not depend on smoking status (adjusted RR [95% CI], 1.23 [0.77&#8211;1.96]). There was no significant difference in the rate of death at 90&#8201;days between the 2 groups (adjusted RR [95% CI], 1.24 [0.68&#8211;2.27]) (Table&#160;<xref rid="jah38674-tbl-0005" ref-type="table">5</xref>).</p></sec></sec><sec sec-type="discussion" id="jah38674-sec-0013"><title>DISCUSSION</title><p>The effects of cigarette smoking on clinical outcomes after spontaneous ICH are poorly understood. Few clinical studies have explored this effect, with conflicting results. Preclinical studies point toward a potential paradoxical neuroprotective effect of nicotine exposure. Herein, we investigated the effect of smoking history on radiologic progression, functional morbidity, and mortality of patients with ICH through a post hoc analysis of the ATACH&#8208;2 trial. Results showed that a history of current or past smoking is associated with significantly higher rates of hematoma expansion, but does not affect mortality, 90&#8208;day disability, 24&#8208;hour neurologic deterioration, or serious adverse event rates.</p><p>Our analysis indicated that ever smokers had a significantly higher rate of hematoma expansion at 24 hours compared with never smokers after adjusting for age, blood pressure goal randomization group, GCS score, intraventricular hemorrhage, sex, and hemorrhage location. This finding is in line with the results of 2 prior retrospective studies that developed models for prediction of hematoma expansion risk in patients with ICH and found smoking to be an independent predictor.<xref rid="jah38674-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref>, <xref rid="jah38674-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> Furthermore, in a recent collagenase&#8208;induced rat ICH model study, the 24&#8208;hour post&#8208;ICH hematoma volume was found to be &gt;40% larger in rats with long&#8208;term nicotine exposure compared with vehicle&#8208;treated rats.<xref rid="jah38674-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref>
</p><p>Smoking can precipitate expansion of the hematoma through several mechanisms.<xref rid="jah38674-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>, <xref rid="jah38674-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> Nicotine is known to cause transient increases in blood pressure,<xref rid="jah38674-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> which can trigger hematoma expansion. Smoking is also known to have deleterious effects on structural integrity of the vessel wall. Both human<xref rid="jah38674-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref> and animal<xref rid="jah38674-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> studies have documented increased numbers of dead anuclear endothelial cells in circulating blood of smokers, and exposure to cigarette smoke has a dose&#8208;dependent negative effect on cerebral vascular endothelial cell viability.<xref rid="jah38674-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> This effect on vascular wall integrity is evidenced by the fact that smoking is a well&#8208;known risk factor for formation, growth, and rupture of cerebral aneurysms.<xref rid="jah38674-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> Another mechanism could be increased blood&#8208;brain barrier permeability in individuals chronically exposed to tobacco. This effect is thought to be mediated by upregulated expression of proinflammatory cytokines,<xref rid="jah38674-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref> particularly tumor necrosis factor&#8208;&#945;,<xref rid="jah38674-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> which, in turn, impair the barrier properties of the blood&#8208;brain barrier.<xref rid="jah38674-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref>, <xref rid="jah38674-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref>, <xref rid="jah38674-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref> Also, NO, which is found abundantly in cigarette smoke, is known to enhance blood&#8211;brain barrier permeability.<xref rid="jah38674-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> Finally, smoking can exacerbate the ICH&#8208;induced secondary neurovascular injury<xref rid="jah38674-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref> through inducing the release of reactive oxygen and nitrogen species<xref rid="jah38674-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref> and propagating an inflammatory milieu via activation of microglial and astrocytic cells,<xref rid="jah38674-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref> matrix metalloproteinases, and release of proinflammatory cytokines.<xref rid="jah38674-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref>
</p><p>Several preclinical studies have indicated a potential neuroprotective effect of nicotine in animal models of ICH. The &#945;7&#8208;nicotinic acetylcholine receptor is widely expressed in neuronal, glial, and immune cells in the mammalian brain.<xref rid="jah38674-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref> Hijioka et al<xref rid="jah38674-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref> found a dose&#8208;dependent reduction in neuron loss and improvements in sensorimotor function and survival in collagenase&#8208;induced ICH rat models injected with intraperitoneal nicotine. Similar results were later achieved in an autologous whole blood murine ICH model.<xref rid="jah38674-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> Such findings hint toward a potential &#8220;smoker's paradox&#8221; effect in the outcomes of patients with ICH, a phenomenon that has been previously described in several vascular conditions.<xref rid="jah38674-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref>
</p><p>However, the hypothesis that smokers have improved outcomes after ICH compared with nonsmokers is not supported by the findings of the current study. We did not observe any significant differences in 90&#8208;day mortality or disability rates, the rate of serious adverse events, or 24&#8208;hour neurologic deterioration. This is in concert with the findings of previous studies in Western populations. Chen et al<xref rid="jah38674-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> did not find any difference in 90&#8208;day mortality, mRS score, or Barthel index between the ever&#8208;smoker and never&#8208;smoker ICH groups in an exploratory analysis of the ERICH (Ethnic/Racial Variations of Intracerebral Hemorrhage) study. Similarly, Ironside et al<xref rid="jah38674-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref> did not find any differences in 90&#8208;day mortality, mRS score, or Barthel index after adjustment for baseline variables between the recent smoker group and either the nonrecent smoker group or the never smoker group in a retrospective review of the ICH Outcomes Project database. Moreover, Sembil et al<xref rid="jah38674-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref> did not find significant differences in 1&#8208;year mortality or favorable outcomes (mRS score, 0&#8211;3) in a propensity&#8208;matched comparison of smoker and nonsmoker ICH groups. Several explanations may clarify a discrepancy of the neuroprotective effect of nicotine in preclinical studies. There is a markedly lower nicotine dose exposure per weight in smoking humans compared with what was achieved in the animal models injected with nicotine.<xref rid="jah38674-bib-0037" ref-type="bibr">
<sup>37</sup>
</xref>, <xref rid="jah38674-bib-0038" ref-type="bibr">
<sup>38</sup>
</xref> In addition, on the basis of the terminal half&#8208;life of nicotine in humans, circulating nicotine levels 48&#8201;hours after having the last smoke would be insignificant.<xref rid="jah38674-bib-0038" ref-type="bibr">
<sup>38</sup>
</xref> As no human study has yet quantitatively documented circulating nicotine levels in patients with ICH who are labeled as &#8220;ever smokers&#8221; or &#8220;current smokers,&#8221; it is unclear what proportion of such subgroups would in fact have nicotine levels sufficient to exert potential neuroprotective effects in the time period after ICH.</p><p>Although some studies, including ours, have not demonstrated worse survival and functional outcomes in smoker patients with ICH compared with nonsmoker patients with ICH, this may be attributable to a short duration of follow&#8208;up. In a cohort of patients with ICH, Xu et al<xref rid="jah38674-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref> demonstrated significantly higher mortality rate in current smokers versus never smokers over 10.9&#8201;years of follow&#8208;up (11.5 versus 6.2 per 10&#8201;000 person&#8208;years, respectively; <italic toggle="yes">P</italic>&lt;0.001). Similar results were achieved by Saloheimo et al<xref rid="jah38674-bib-0039" ref-type="bibr">
<sup>39</sup>
</xref> in a 7&#8208;year study of prognostic factors in ICH survivors. Several population&#8208;based long&#8208;term prospective studies designed to study risk factors of stroke have also found smoking to be associated with higher mortality in patients with ICH.<xref rid="jah38674-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="jah38674-bib-0040" ref-type="bibr">
<sup>40</sup>
</xref>, <xref rid="jah38674-bib-0041" ref-type="bibr">
<sup>41</sup>
</xref>, <xref rid="jah38674-bib-0042" ref-type="bibr">
<sup>42</sup>
</xref>
</p><p>In our study, ever&#8208;smoker patients with ICH tended to be significantly younger than never smokers, in line with prior studies.<xref rid="jah38674-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>, <xref rid="jah38674-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref> This potentially highlights detrimental effects of smoking on cerebrovascular health. Furthermore, the odds of intraventricular extension of the ICH were significantly higher in ever smokers. This could be attributable to chronic microangiopathy and blood&#8211;brain barrier disruption caused by smoking, which can facilitate small&#8208;vessel bleeding and extension.</p><p>We acknowledge several limitations of the current study. First, information about smoking was provided by patients and/or their family members, which is prone to recall, reporting, and missing data bias. Data about duration and intensity of smoking, or the exposure levels at the time of ICH or afterwards, were not collected. Pooling current and former smokers into 1 &#8220;ever&#8208;smoker&#8221; group is also associated with limitations, especially given that differential short&#8208; and long&#8208;term effects of each tobacco smoke component are not entirely understood. We have provided separate analyses for current, former, and never smoker groups to address this limitation. The study was not equipped to explore long&#8208;term effects of smoking on ICH outcomes given the 90&#8208;day duration of follow&#8208;up. Last, this was a post hoc analysis of the ATACH&#8208;2 clinical trial data, so the study protocol was not specifically designed to compare outcomes of ICH based on smoking status, and this post hoc analysis is limited to the variables included in the initial study design. Strengths of the study include large study size, use of rigorous clinical trial data, and adequately accounting for confounding factors other than smoking (eg, age, hematoma location, GCS score, and intraventricular hemorrhage) that can affect ICH outcomes through use of multivariate statistical models.</p></sec><sec sec-type="conclusions" id="jah38674-sec-0014"><title>CONCLUSIONS</title><p>Our analysis in a large group of hypertensive patients with ICH demonstrates that cigarette smoking is an independent predictor for hematoma expansion. There was no significant difference in death and disability based on smoking status. These findings do not support the &#8220;smoker's paradox&#8221; hypothesis, and they indicate that neuroprotective effects of nicotine, if any, are likely offset by detrimental microangiopathic and inflammatory effects of smoking, which result in a higher risk of hematoma expansion. Further studies are warranted to fully understand the impact of smoking on clinical outcome in patients with hypertensive ICH.</p></sec><sec id="jah38674-sec-0015"><title>APPENDIX</title><sec id="jah38674-sec-0016"><title>ATACH&#8208;2 Trial Investigators</title><p>Zeenat Qureshi Stroke Research Center, University of Minnesota, Minneapolis (Adnan I. Qureshi).</p><p>Department of Public Health Sciences, Medical University of South Carolina, Charleston (Yuko Y. Palesch and Renee L. Martin).</p><p>Department of Emergency Medicine, University of Michigan, Ann Arbor (William G. Barsan and Robert Silbergleit).</p><p>Division of Brain Injury Outcomes, Johns Hopkins University, Baltimore, MD (Daniel F. Hanley).</p><p>Neurological Institute, National Institute of Neurological Disorders and Stroke, Bethesda, MD (Claudia S. Moy).</p><p>China Medical University, Taichung, Taiwan (Chung Y. Hsu).</p><p>Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany (Thorsten Steiner).</p><p>Department of Neurology, Baylor College of Medicine, Houston, TX (Jose I. Suarez).</p><p>Departments of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan (Kazunori Toyoda).</p><p>Beijing Tiantan Hospital, Beijing, China (Yongjun Wang).</p><p>Departments of Data Sciences, National Cerebral and Cardiovascular Center, Suita, Japan (Haruko Yamamoto).</p><p>Department of Neurology, Seoul National University Hospital, Seoul, South Korea (Byung&#8208;Woo Yoon).</p><p>Adnan I. Qureshi, Yuko Y. Palesch, Renee L. Martin, William G. Barsan, Robert Silbergleit, Daniel F. Hanley, Claudia S. Moy, Chung Y. Hsu, Thorsten Steiner, Jose I. Suarez, Kazunori Toyoda, Yongjun Wang, Haruko Yamamoto, Byung&#8208;Woo Yoon</p></sec></sec><sec id="jah38674-sec-0017"><title>Sources of Funding</title><p>None.</p></sec><sec id="jah38674-sec-0018"><title>Disclosures</title><p>None.</p></sec></body><back><ref-list content-type="cited-references" id="jah38674-bibl-0001"><title>References</title><ref id="jah38674-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="jah38674-cit-0001"><string-name name-style="western"><surname>Feigin</surname><given-names>VL</given-names></string-name>, <string-name name-style="western"><surname>Lawes</surname><given-names>CMM</given-names></string-name>, <string-name name-style="western"><surname>Bennett</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Barker&#8208;Collo</surname><given-names>SL</given-names></string-name>, <string-name name-style="western"><surname>Parag</surname><given-names>V</given-names></string-name>. <article-title>Worldwide stroke incidence and early case fatality reported in 56 population&#8208;based studies: a systematic review</article-title>. <source>Lancet Neurol</source>. <year>2009</year>;<volume>8</volume>:<fpage>355</fpage>&#8211;<lpage>369</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S1474-4422(09)70025-0</pub-id><pub-id pub-id-type="pmid">19233729</pub-id></mixed-citation></ref><ref id="jah38674-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="jah38674-cit-0002"><string-name name-style="western"><surname>Sacco</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Marini</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Toni</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Olivieri</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Carolei</surname><given-names>A</given-names></string-name>. <article-title>Incidence and 10&#8208;year survival of intracerebral hemorrhage in a population&#8208;based registry</article-title>. <source>Stroke</source>. <year>2009</year>;<volume>40</volume>:<fpage>394</fpage>&#8211;<lpage>399</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STROKEAHA.108.523209</pub-id><pub-id pub-id-type="pmid">19038914</pub-id></mixed-citation></ref><ref id="jah38674-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="jah38674-cit-0003"><collab collab-type="authors">GBD 2019 Stroke Collaborators</collab>
. <article-title>Global, regional, and national burden of stroke and its risk factors, 1990&#8211;2019: a systematic analysis for the Global Burden of Disease Study 2019</article-title>. <source>Lancet Neurol</source>. <year>2021</year>;<volume>20</volume>:<fpage>795</fpage>&#8211;<lpage>820</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S1474-4422(21)00252-0</pub-id><pub-id pub-id-type="pmid">34487721</pub-id><pub-id pub-id-type="pmcid">PMC8443449</pub-id></mixed-citation></ref><ref id="jah38674-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="jah38674-cit-0004"><string-name name-style="western"><surname>Xu</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Schooling</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Chan</surname><given-names>WM</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>SY</given-names></string-name>, <string-name name-style="western"><surname>Leung</surname><given-names>GM</given-names></string-name>, <string-name name-style="western"><surname>Lam</surname><given-names>TH</given-names></string-name>. <article-title>Smoking and hemorrhagic stroke mortality in a prospective cohort study of older Chinese</article-title>. <source>Stroke</source>. <year>2013</year>;<volume>44</volume>:<fpage>2144</fpage>&#8211;<lpage>2149</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STROKEAHA.113.001500</pub-id><pub-id pub-id-type="pmid">23723306</pub-id></mixed-citation></ref><ref id="jah38674-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="jah38674-cit-0005"><string-name name-style="western"><surname>Kurth</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Kase</surname><given-names>CS</given-names></string-name>, <string-name name-style="western"><surname>Berger</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Schaeffner</surname><given-names>ES</given-names></string-name>, <string-name name-style="western"><surname>Buring</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Gaziano</surname><given-names>JM</given-names></string-name>. <article-title>Smoking and the risk of hemorrhagic stroke in men</article-title>. <source>Stroke</source>. <year>2003</year>;<volume>34</volume>:<fpage>1151</fpage>&#8211;<lpage>1155</lpage>. doi: <pub-id pub-id-type="doi">10.1161/01.STR.0000065200.93070.32</pub-id><pub-id pub-id-type="pmid">12663877</pub-id></mixed-citation></ref><ref id="jah38674-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="jah38674-cit-0006"><string-name name-style="western"><surname>Ariesen</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Claus</surname><given-names>SP</given-names></string-name>, <string-name name-style="western"><surname>Rinkel</surname><given-names>GJE</given-names></string-name>, <string-name name-style="western"><surname>Algra</surname><given-names>A</given-names></string-name>. <article-title>Risk factors for intracerebral hemorrhage in the general population: a systematic review</article-title>. <source>Stroke</source>. <year>2003</year>;<volume>34</volume>:<fpage>2060</fpage>&#8211;<lpage>2065</lpage>. doi: <pub-id pub-id-type="doi">10.1161/01.STR.0000080678.09344.8D</pub-id><pub-id pub-id-type="pmid">12843354</pub-id></mixed-citation></ref><ref id="jah38674-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="jah38674-cit-0007"><string-name name-style="western"><surname>Hauer</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Ruigrok</surname><given-names>YM</given-names></string-name>, <string-name name-style="western"><surname>Algra</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>van Dijk</surname><given-names>EJ</given-names></string-name>, <string-name name-style="western"><surname>Koudstaal</surname><given-names>PJ</given-names></string-name>, <string-name name-style="western"><surname>Luijckx</surname><given-names>GJ</given-names></string-name>, <string-name name-style="western"><surname>Nederkoorn</surname><given-names>PJ</given-names></string-name>, <string-name name-style="western"><surname>van Oostenbrugge</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Visser</surname><given-names>MC</given-names></string-name>, <string-name name-style="western"><surname>Wermer</surname><given-names>MJ</given-names></string-name>, et al; <article-title>Dutch Parelsnoer Institute&#8208;Cerebrovascular Accident Study Group. Age&#8208;specific vascular risk factor profiles according to stroke subtype</article-title>. <source>J Am Heart Assoc</source>. <year>2017</year>;<volume>6</volume>:<elocation-id>e005090</elocation-id>. doi: <pub-id pub-id-type="doi">10.1161/JAHA.116.005090</pub-id><pub-id pub-id-type="pmid">28483775</pub-id><pub-id pub-id-type="pmcid">PMC5524074</pub-id></mixed-citation></ref><ref id="jah38674-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="jah38674-cit-0008"><string-name name-style="western"><surname>Nakamura</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Barzi</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Lam</surname><given-names>TH</given-names></string-name>, <string-name name-style="western"><surname>Huxley</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Feigin</surname><given-names>VL</given-names></string-name>, <string-name name-style="western"><surname>Ueshima</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Woo</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Gu</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Ohkubo</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Lawes</surname><given-names>CM</given-names></string-name>, et al;. <article-title>Asia Pacific Cohort Studies Collaboration. Cigarette smoking, systolic blood pressure, and cardiovascular diseases in the Asia&#8208;Pacific region</article-title>. <source>Stroke</source>. <year>2008</year>;<volume>39</volume>:<fpage>1694</fpage>&#8211;<lpage>1702</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STROKEAHA.107.496752</pub-id><pub-id pub-id-type="pmid">18323508</pub-id></mixed-citation></ref><ref id="jah38674-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="jah38674-cit-0009"><string-name name-style="western"><surname>Krafft</surname><given-names>PR</given-names></string-name>, <string-name name-style="western"><surname>Altay</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Rolland</surname><given-names>WB</given-names></string-name>, <string-name name-style="western"><surname>Duris</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Lekic</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Tang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>JH</given-names></string-name>. <article-title>&#945;7 nicotinic acetylcholine receptor agonism confers neuroprotection through GSK&#8208;3&#946; inhibition in a mouse model of intracerebral hemorrhage</article-title>. <source>Stroke</source>. <year>2012</year>;<volume>43</volume>:<fpage>844</fpage>&#8211;<lpage>850</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STROKEAHA.111.639989</pub-id><pub-id pub-id-type="pmid">22207510</pub-id><pub-id pub-id-type="pmcid">PMC3293395</pub-id></mixed-citation></ref><ref id="jah38674-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="jah38674-cit-0010"><string-name name-style="western"><surname>Chen</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Ding</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Ironside</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Buell</surname><given-names>TJ</given-names></string-name>, <string-name name-style="western"><surname>Southerland</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Koch</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Flaherty</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Woo</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Worrall</surname><given-names>BB</given-names></string-name>; <collab collab-type="authors">ERICH Investigators</collab>
. <article-title>Cigarette smoking history and functional outcomes after spontaneous intracerebral hemorrhage</article-title>. <source>Stroke</source>. <year>2019</year>;<volume>50</volume>:<fpage>588</fpage>&#8211;<lpage>594</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STROKEAHA.118.023580</pub-id><pub-id pub-id-type="pmid">30732556</pub-id><pub-id pub-id-type="pmcid">PMC6389405</pub-id></mixed-citation></ref><ref id="jah38674-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="jah38674-cit-0011"><string-name name-style="western"><surname>Sembill</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Spr&#252;gel</surname><given-names>MI</given-names></string-name>, <string-name name-style="western"><surname>Gerner</surname><given-names>ST</given-names></string-name>, <string-name name-style="western"><surname>Beuscher</surname><given-names>VD</given-names></string-name>, <string-name name-style="western"><surname>Giede&#8208;Jeppe</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Stocker</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Hoelter</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>L&#252;cking</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Kuramatsu</surname><given-names>JB</given-names></string-name>, <string-name name-style="western"><surname>Huttner</surname><given-names>HB</given-names></string-name>. <article-title>Influence of prior nicotine and alcohol use on functional outcome in patients after intracerebral hemorrhage</article-title>. <source>J Stroke Cerebrovasc Dis</source>. <year>2018</year>;<volume>27</volume>:<fpage>892</fpage>&#8211;<lpage>899</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jstrokecerebrovasdis.2017.10.029</pub-id><pub-id pub-id-type="pmid">29191740</pub-id></mixed-citation></ref><ref id="jah38674-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="jah38674-cit-0012"><string-name name-style="western"><surname>Yao</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Xu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Siwila&#8208;Sackman</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Selim</surname><given-names>M</given-names></string-name>. <article-title>The HEP score: a nomogram&#8208;derived hematoma expansion prediction scale</article-title>. <source>Neurocrit Care</source>. <year>2015</year>;<volume>23</volume>:<fpage>179</fpage>&#8211;<lpage>187</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12028-015-0147-4</pub-id><pub-id pub-id-type="pmid">25963292</pub-id></mixed-citation></ref><ref id="jah38674-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="jah38674-cit-0013"><string-name name-style="western"><surname>Liang</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>HJ</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>YC</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>CC</given-names></string-name>, <string-name name-style="western"><surname>Tsai</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>PL</given-names></string-name>, <string-name name-style="western"><surname>Chang</surname><given-names>WL</given-names></string-name>, <string-name name-style="western"><surname>Yeh</surname><given-names>PY</given-names></string-name>, <string-name name-style="western"><surname>Wei</surname><given-names>CY</given-names></string-name>, <string-name name-style="western"><surname>Tsai</surname><given-names>MJ</given-names></string-name>, et al. <article-title>Smoking status and functional outcomes in young stroke</article-title>. <source>Front Neurol</source>. <year>2021</year>;<volume>12</volume>:<elocation-id>658582</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fneur.2021.658582</pub-id><pub-id pub-id-type="pmid">34539539</pub-id><pub-id pub-id-type="pmcid">PMC8440842</pub-id></mixed-citation></ref><ref id="jah38674-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="jah38674-cit-0014"><string-name name-style="western"><surname>Qureshi</surname><given-names>AI</given-names></string-name>, <string-name name-style="western"><surname>Palesch</surname><given-names>YY</given-names></string-name>. <article-title>Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale</article-title>. <source>Neurocrit Care</source>. <year>2011</year>;<volume>15</volume>:<fpage>559</fpage>&#8211;<lpage>576</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12028-011-9538-3</pub-id><pub-id pub-id-type="pmid">21626077</pub-id><pub-id pub-id-type="pmcid">PMC3340125</pub-id></mixed-citation></ref><ref id="jah38674-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="jah38674-cit-0015"><string-name name-style="western"><surname>Qureshi</surname><given-names>AI</given-names></string-name>, <string-name name-style="western"><surname>Palesch</surname><given-names>YY</given-names></string-name>, <string-name name-style="western"><surname>Barsan</surname><given-names>WG</given-names></string-name>, <string-name name-style="western"><surname>Hanley</surname><given-names>DF</given-names></string-name>, <string-name name-style="western"><surname>Hsu</surname><given-names>CY</given-names></string-name>, <string-name name-style="western"><surname>Martin</surname><given-names>RL</given-names></string-name>, <string-name name-style="western"><surname>Moy</surname><given-names>CS</given-names></string-name>, <string-name name-style="western"><surname>Silbergleit</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Steiner</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Suarez</surname><given-names>JI</given-names></string-name>, et al; <article-title>ATACH&#8208;2 Trial Investigators and the Neurological Emergency Treatment Trials Network. Intensive blood&#8208;pressure lowering in patients with acute cerebral hemorrhage</article-title>. <source>N Engl J Med</source>. <year>2016</year>;<volume>375</volume>:<fpage>1033</fpage>&#8211;<lpage>1043</lpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJMoa1603460</pub-id><pub-id pub-id-type="pmid">27276234</pub-id><pub-id pub-id-type="pmcid">PMC5345109</pub-id></mixed-citation></ref><ref id="jah38674-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="jah38674-cit-0016"><string-name name-style="western"><surname>Wang</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Du</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Sheng</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Jiang</surname><given-names>R</given-names></string-name>. <article-title>Computed tomography and clinical parameters predict intracerebral hemorrhage expansion</article-title>. <source>Medicine (Baltimore)</source>. <year>2022</year>;<volume>101</volume>:<elocation-id>e28912</elocation-id>. doi: <pub-id pub-id-type="doi">10.1097/MD.0000000000028912</pub-id><pub-id pub-id-type="pmid">35244045</pub-id><pub-id pub-id-type="pmcid">PMC8896498</pub-id></mixed-citation></ref><ref id="jah38674-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="jah38674-cit-0017"><string-name name-style="western"><surname>Rehni</surname><given-names>AK</given-names></string-name>, <string-name name-style="western"><surname>Cho</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Raval</surname><given-names>AP</given-names></string-name>, <string-name name-style="western"><surname>Perez&#8208;Pinzon</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Dave</surname><given-names>KR</given-names></string-name>. <article-title>Chronic nicotine exposure increases hematoma expansion following collagenase&#8208;induced intracerebral hemorrhage in rats</article-title>. <source>Biomolecules</source>. <year>2022</year>;<volume>12</volume>:<fpage>621</fpage>. doi: <pub-id pub-id-type="doi">10.3390/biom12050621</pub-id><pub-id pub-id-type="pmid">35625548</pub-id><pub-id pub-id-type="pmcid">PMC9138464</pub-id></mixed-citation></ref><ref id="jah38674-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="jah38674-cit-0018"><string-name name-style="western"><surname>Cho</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Rehni</surname><given-names>AK</given-names></string-name>, <string-name name-style="western"><surname>Dave</surname><given-names>KR</given-names></string-name>. <article-title>Tobacco use: a major risk factor of intracerebral hemorrhage</article-title>. <source>J Stroke</source>. <year>2021</year>;<volume>23</volume>:<fpage>37</fpage>&#8211;<lpage>50</lpage>. doi: <pub-id pub-id-type="doi">10.5853/jos.2020.04770</pub-id><pub-id pub-id-type="pmid">33600701</pub-id><pub-id pub-id-type="pmcid">PMC7900392</pub-id></mixed-citation></ref><ref id="jah38674-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="jah38674-cit-0019"><string-name name-style="western"><surname>Mazzone</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Tierney</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Hossain</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Puvenna</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Janigro</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Cucullo</surname><given-names>L</given-names></string-name>. <article-title>Pathophysiological impact of cigarette smoke exposure on the cerebrovascular system with a focus on the blood&#8208;brain barrier: expanding the awareness of smoking toxicity in an underappreciated area</article-title>. <source>Int J Environ Res Public Health</source>. <year>2010</year>;<volume>7</volume>:<fpage>4111</fpage>&#8211;<lpage>4126</lpage>. doi: <pub-id pub-id-type="doi">10.3390/ijerph7124111</pub-id><pub-id pub-id-type="pmid">21317997</pub-id><pub-id pub-id-type="pmcid">PMC3037043</pub-id></mixed-citation></ref><ref id="jah38674-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="jah38674-cit-0020"><string-name name-style="western"><surname>Benowitz</surname><given-names>NL</given-names></string-name>, <string-name name-style="western"><surname>Burbank</surname><given-names>AD</given-names></string-name>. <article-title>Cardiovascular toxicity of nicotine: implications for electronic cigarette use</article-title>. <source>Trends Cardiovasc Med</source>. <year>2016</year>;<volume>26</volume>:<fpage>515</fpage>&#8211;<lpage>523</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tcm.2016.03.001</pub-id><pub-id pub-id-type="pmid">27079891</pub-id><pub-id pub-id-type="pmcid">PMC4958544</pub-id></mixed-citation></ref><ref id="jah38674-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="jah38674-cit-0021"><string-name name-style="western"><surname>Blache</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Bouthillier</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Davignon</surname><given-names>J</given-names></string-name>. <article-title>Acute influence of smoking on platelet behaviour, endothelium and plasma lipids and normalization by aspirin</article-title>. <source>Atherosclerosis</source>. <year>1992</year>;<volume>93</volume>:<fpage>179</fpage>&#8211;<lpage>188</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0021-9150(92)90254-e</pub-id><pub-id pub-id-type="pmid">1534226</pub-id></mixed-citation></ref><ref id="jah38674-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="jah38674-cit-0022"><string-name name-style="western"><surname>Hladovec</surname><given-names>J</given-names></string-name>. <article-title>Endothelial injury by nicotine and its prevention</article-title>. <source>Experientia</source>. <year>1978</year>;<volume>34</volume>:<fpage>1585</fpage>&#8211;<lpage>1586</lpage>. doi: <pub-id pub-id-type="doi">10.1007/BF02034689</pub-id><pub-id pub-id-type="pmid">729720</pub-id></mixed-citation></ref><ref id="jah38674-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="jah38674-cit-0023"><string-name name-style="western"><surname>Hossain</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Sathe</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Fazio</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Mazzone</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Weksler</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Janigro</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Rapp</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Cucullo</surname><given-names>L</given-names></string-name>. <article-title>Tobacco smoke: a critical etiological factor for vascular impairment at the blood&#8208;brain barrier</article-title>. <source>Brain Res</source>. <year>2009</year>;<volume>1287</volume>:<fpage>192</fpage>&#8211;<lpage>205</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.brainres.2009.06.033</pub-id><pub-id pub-id-type="pmid">19539613</pub-id><pub-id pub-id-type="pmcid">PMC2831230</pub-id></mixed-citation></ref><ref id="jah38674-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="jah38674-cit-0024"><string-name name-style="western"><surname>Juvela</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Porras</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Poussa</surname><given-names>K</given-names></string-name>. <article-title>Natural history of unruptured intracranial aneurysms: probability of and risk factors for aneurysm rupture</article-title>. <source>J Neurosurg</source>. <year>2008</year>;<volume>108</volume>:<fpage>1052</fpage>&#8211;<lpage>1060</lpage>. doi: <pub-id pub-id-type="doi">10.3171/JNS/2008/108/5/1052</pub-id><pub-id pub-id-type="pmid">18447733</pub-id></mixed-citation></ref><ref id="jah38674-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="jah38674-cit-0025"><string-name name-style="western"><surname>Bradford</surname><given-names>ST</given-names></string-name>, <string-name name-style="western"><surname>Stamatovic</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Dondeti</surname><given-names>RS</given-names></string-name>, <string-name name-style="western"><surname>Keep</surname><given-names>RF</given-names></string-name>, <string-name name-style="western"><surname>Andjelkovic</surname><given-names>AV</given-names></string-name>. <article-title>Nicotine aggravates the brain postischemic inflammatory response</article-title>. <source>Am J Physiol Heart Circ Physiol</source>. <year>2011</year>;<volume>300</volume>:<fpage>H1518</fpage>&#8211;<lpage>H1529</lpage>. doi: <pub-id pub-id-type="doi">10.1152/ajpheart.00928.2010</pub-id><pub-id pub-id-type="pmid">21239632</pub-id><pub-id pub-id-type="pmcid">PMC3075028</pub-id></mixed-citation></ref><ref id="jah38674-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="jah38674-cit-0026"><string-name name-style="western"><surname>Malovichko</surname><given-names>MV</given-names></string-name>, <string-name name-style="western"><surname>Zeller</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Krivokhizhina</surname><given-names>TV</given-names></string-name>, <string-name name-style="western"><surname>Xie</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Lorkiewicz</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Agarwal</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Wickramasinghe</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Sithu</surname><given-names>SD</given-names></string-name>, <string-name name-style="western"><surname>Shah</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>O'Toole</surname><given-names>T</given-names></string-name>, et al. <article-title>Systemic toxicity of smokeless tobacco products in mice</article-title>. <source>Nicotine Tob Res</source>. <year>2019</year>;<volume>21</volume>:<fpage>101</fpage>&#8211;<lpage>110</lpage>. doi: <pub-id pub-id-type="doi">10.1093/ntr/ntx230</pub-id><pub-id pub-id-type="pmid">30085294</pub-id><pub-id pub-id-type="pmcid">PMC6329408</pub-id></mixed-citation></ref><ref id="jah38674-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="jah38674-cit-0027"><string-name name-style="western"><surname>Marcos&#8208;Ramiro</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Garc&#237;a&#8208;Weber</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Mill&#225;n</surname><given-names>J</given-names></string-name>. <article-title>TNF&#8208;induced endothelial barrier disruption: beyond actin and Rho</article-title>. <source>Thromb Haemost</source>. <year>2014</year>;<volume>112</volume>:<fpage>1088</fpage>&#8211;<lpage>1102</lpage>. doi: <pub-id pub-id-type="doi">10.1160/TH14-04-0299</pub-id><pub-id pub-id-type="pmid">25078148</pub-id></mixed-citation></ref><ref id="jah38674-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="jah38674-cit-0028"><string-name name-style="western"><surname>Ferrero</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Villa</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Ferrero</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Toninelli</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Bender</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Pardi</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Zocchi</surname><given-names>MR</given-names></string-name>. <article-title>Tumor necrosis factor alpha&#8208;induced vascular leakage involves PECAM1 phosphorylation</article-title>. <source>Cancer Res</source>. <year>1996</year>;<volume>56</volume>:<fpage>3211</fpage>&#8211;<lpage>3215</lpage>. doi: <pub-id pub-id-type="doi">10.1160/TH14-04-0299</pub-id><pub-id pub-id-type="pmid">8764109</pub-id></mixed-citation></ref><ref id="jah38674-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="jah38674-cit-0029"><string-name name-style="western"><surname>Hawkins</surname><given-names>BT</given-names></string-name>, <string-name name-style="western"><surname>Abbruscato</surname><given-names>TJ</given-names></string-name>, <string-name name-style="western"><surname>Egleton</surname><given-names>RD</given-names></string-name>, <string-name name-style="western"><surname>Brown</surname><given-names>RC</given-names></string-name>, <string-name name-style="western"><surname>Huber</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>Campos</surname><given-names>CR</given-names></string-name>, <string-name name-style="western"><surname>Davis</surname><given-names>TP</given-names></string-name>. <article-title>Nicotine increases in vivo blood&#8208;brain barrier permeability and alters cerebral microvascular tight junction protein distribution</article-title>. <source>Brain Res</source>. <year>2004</year>;<volume>1027</volume>:<fpage>48</fpage>&#8211;<lpage>58</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.brainres.2004.08.043</pub-id><pub-id pub-id-type="pmid">15494156</pub-id></mixed-citation></ref><ref id="jah38674-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="jah38674-cit-0030"><string-name name-style="western"><surname>Xi</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Keep</surname><given-names>RF</given-names></string-name>, <string-name name-style="western"><surname>Hoff</surname><given-names>JT</given-names></string-name>. <article-title>Mechanisms of brain injury after intracerebral haemorrhage</article-title>. <source>Lancet Neurol</source>. <year>2006</year>;<volume>5</volume>:<fpage>53</fpage>&#8211;<lpage>63</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S1474-4422(05)70283-0</pub-id><pub-id pub-id-type="pmid">16361023</pub-id></mixed-citation></ref><ref id="jah38674-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="jah38674-cit-0031"><string-name name-style="western"><surname>Naik</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Fofaria</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Prasad</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Sajja</surname><given-names>RK</given-names></string-name>, <string-name name-style="western"><surname>Weksler</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Couraud</surname><given-names>PO</given-names></string-name>, <string-name name-style="western"><surname>Romero</surname><given-names>IA</given-names></string-name>, <string-name name-style="western"><surname>Cucullo</surname><given-names>L</given-names></string-name>. <article-title>Oxidative and pro&#8208;inflammatory impact of regular and denicotinized cigarettes on blood brain barrier endothelial cells: is smoking reduced or nicotine&#8208;free products really safe?</article-title><source>BMC Neurosci</source>. <year>2014</year>;<volume>15</volume>:<fpage>51</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1471-2202-15-51</pub-id><pub-id pub-id-type="pmid">24755281</pub-id><pub-id pub-id-type="pmcid">PMC4020608</pub-id></mixed-citation></ref><ref id="jah38674-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="jah38674-cit-0032"><string-name name-style="western"><surname>Ghosh</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Mishra</surname><given-names>MK</given-names></string-name>, <string-name name-style="western"><surname>Das</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Kaushik</surname><given-names>DK</given-names></string-name>, <string-name name-style="western"><surname>Basu</surname><given-names>A</given-names></string-name>. <article-title>Tobacco carcinogen induces microglial activation and subsequent neuronal damage</article-title>. <source>J Neurochem</source>. <year>2009</year>;<volume>110</volume>:<fpage>1070</fpage>&#8211;<lpage>1081</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.06203.x</pub-id><pub-id pub-id-type="pmid">19500213</pub-id></mixed-citation></ref><ref id="jah38674-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="jah38674-cit-0033"><string-name name-style="western"><surname>Sussman</surname><given-names>ES</given-names></string-name>, <string-name name-style="western"><surname>Kellner</surname><given-names>CP</given-names></string-name>, <string-name name-style="western"><surname>McDowell</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>Bruce</surname><given-names>SS</given-names></string-name>, <string-name name-style="western"><surname>Heuts</surname><given-names>SG</given-names></string-name>, <string-name name-style="western"><surname>Zhuang</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Bruce</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Claassen</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Connolly</surname><given-names>ES</given-names><suffix>Jr</suffix></string-name>. <article-title>Alpha&#8208;7 nicotinic acetylcholine receptor agonists in intracerebral hemorrhage: an evaluation of the current evidence for a novel therapeutic agent</article-title>. <source>Neurosurg Focus</source>. <year>2013</year>;<volume>34</volume>:<fpage>E10</fpage>. doi: <pub-id pub-id-type="doi">10.3171/2013.2.FOCUS1315</pub-id><pub-id pub-id-type="pmid">23634914</pub-id></mixed-citation></ref><ref id="jah38674-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="jah38674-cit-0034"><string-name name-style="western"><surname>Hijioka</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Matsushita</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Hisatsune</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Isohama</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Katsuki</surname><given-names>H</given-names></string-name>. <article-title>Therapeutic effect of nicotine in a mouse model of intracerebral hemorrhage</article-title>. <source>J Pharmacol Exp Ther</source>. <year>2011</year>;<volume>338</volume>:<fpage>741</fpage>&#8211;<lpage>749</lpage>. doi: <pub-id pub-id-type="doi">10.1124/jpet.111.182519</pub-id><pub-id pub-id-type="pmid">21610140</pub-id></mixed-citation></ref><ref id="jah38674-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="jah38674-cit-0035"><string-name name-style="western"><surname>Kirtane</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Kelly</surname><given-names>CR</given-names></string-name>. <article-title>Clearing the air on the &#8220;smoker's paradox&#8221;</article-title>. <source>J Am Coll Cardiol</source>. <year>2015</year>;<volume>65</volume>:<fpage>1116</fpage>&#8211;<lpage>1118</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jacc.2015.01.012</pub-id><pub-id pub-id-type="pmid">25790883</pub-id></mixed-citation></ref><ref id="jah38674-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="jah38674-cit-0036"><string-name name-style="western"><surname>Ironside</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Pucci</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Connolly</surname><given-names>ES</given-names></string-name>. <article-title>Effect of cigarette smoking on functional outcomes in patients with spontaneous intracerebral hemorrhage</article-title>. <source>J Stroke Cerebrovasc Dis</source>. <year>2019</year>;<volume>28</volume>:<fpage>2496</fpage>&#8211;<lpage>2505</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jstrokecerebrovasdis.2019.06.013</pub-id><pub-id pub-id-type="pmid">31279697</pub-id></mixed-citation></ref><ref id="jah38674-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="jah38674-cit-0037"><string-name name-style="western"><surname>Hijioka</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Matsushita</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Ishibashi</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Hisatsune</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Isohama</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Katsuki</surname><given-names>H</given-names></string-name>. <article-title>&#945;7 Nicotinic acetylcholine receptor agonist attenuates neuropathological changes associated with intracerebral hemorrhage in mice</article-title>. <source>Neuroscience</source>. <year>2012</year>;<volume>222</volume>:<fpage>10</fpage>&#8211;<lpage>19</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuroscience.2012.07.024</pub-id><pub-id pub-id-type="pmid">22820264</pub-id></mixed-citation></ref><ref id="jah38674-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="jah38674-cit-0038"><string-name name-style="western"><surname>Marchand</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Brossard</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Merdjan</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Lama</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Weitkunat</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>L&#252;dicke</surname><given-names>F</given-names></string-name>. <article-title>Nicotine population pharmacokinetics in healthy adult smokers: a retrospective analysis</article-title>. <source>Eur J Drug Metab Pharmacokinet</source>. <year>2017</year>;<volume>42</volume>:<fpage>943</fpage>&#8211;<lpage>954</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s13318-017-0405-2</pub-id><pub-id pub-id-type="pmid">28283988</pub-id><pub-id pub-id-type="pmcid">PMC5681983</pub-id></mixed-citation></ref><ref id="jah38674-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="jah38674-cit-0039"><string-name name-style="western"><surname>Saloheimo</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Lapp</surname><given-names>TM</given-names></string-name>, <string-name name-style="western"><surname>Juvela</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Hillbom</surname><given-names>M</given-names></string-name>. <article-title>The impact of functional status at three months on long&#8208;term survival after spontaneous intracerebral hemorrhage</article-title>. <source>Stroke</source>. <year>2006</year>;<volume>37</volume>:<fpage>487</fpage>&#8211;<lpage>491</lpage>. doi: <pub-id pub-id-type="doi">10.1161/01.STR.0000198868.78546.fc</pub-id><pub-id pub-id-type="pmid">16373642</pub-id></mixed-citation></ref><ref id="jah38674-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="jah38674-cit-0040"><string-name name-style="western"><surname>Neaton</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>Wentworth</surname><given-names>DN</given-names></string-name>, <string-name name-style="western"><surname>Cutler</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Stamler</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Kuller</surname><given-names>L</given-names></string-name>. <article-title>Risk factors for death from different types of stroke. Multiple Risk Factor Intervention Trial Research Group</article-title>. <source>Ann Epidemiol</source>. <year>1993</year>;<volume>3</volume>:<fpage>493</fpage>&#8211;<lpage>499</lpage>. doi: <pub-id pub-id-type="doi">10.1016/1047-2797(93)90103-b</pub-id><pub-id pub-id-type="pmid">8167825</pub-id></mixed-citation></ref><ref id="jah38674-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="jah38674-cit-0041"><string-name name-style="western"><surname>Martiniuk</surname><given-names>ALC</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>CMY</given-names></string-name>, <string-name name-style="western"><surname>Lam</surname><given-names>TH</given-names></string-name>, <string-name name-style="western"><surname>Huxley</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Suh</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Jamrozik</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Gu</surname><given-names>DF</given-names></string-name>, <string-name name-style="western"><surname>Woodward</surname><given-names>M</given-names></string-name>; <collab collab-type="authors">Asia Pacific Cohort Studies Collaboration</collab>
. <article-title>The fraction of ischaemic heart disease and stroke attributable to smoking in the WHO Western Pacific and South&#8208;East Asian regions</article-title>. <source>Tob Control</source>. <year>2006</year>;<volume>15</volume>:<fpage>181</fpage>&#8211;<lpage>188</lpage>. doi: <pub-id pub-id-type="doi">10.1136/tc.2005.013284</pub-id><pub-id pub-id-type="pmid">16728748</pub-id><pub-id pub-id-type="pmcid">PMC2564655</pub-id></mixed-citation></ref><ref id="jah38674-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="jah38674-cit-0042"><string-name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Tuomilehto</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Jousilahti</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Antikainen</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>G</given-names></string-name>. <article-title>Lifestyle factors on the risks of ischemic and hemorrhagic stroke</article-title>. <source>Arch Intern Med</source>. <year>2011</year>;<volume>171</volume>:<fpage>1811</fpage>&#8211;<lpage>1818</lpage>. doi: <pub-id pub-id-type="doi">10.1001/archinternmed.2011.443</pub-id><pub-id pub-id-type="pmid">21911621</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>